Stereotactic Body Radiation Therapy (SBRT) for Select Pancreatic Cancer Patients
Stereotactic body radiation therapy (SBRT) is increasingly being used to treat locally advanced pancreatic cancer, and make it surgically removable.
Currently in the Fight, at Memorial Sloan Kettering Cancer Center
A woman's treatment for non-operable pancreatic cancer at Memorial Sloan Kettering includes FOLFIRINOX and stereotactic body radiation therapy.
Conventionally Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer (CRiSP): An International Systematic Review and Meta‐Analysis
The primary outcome measure was efficacy, defined by 2‐year overall survival (OS). Secondary outcomes were incidence of any grade 3/4…
Stereotactic Body Radiotherapy Promising for Pancreatic Cancer
Five-year survival rates for patients with pancreatic cancer remain low, at less than 8%. Complete surgical resection extends survival. However,…
Stereotactic Body Radiation Therapy Improves OS for Locally Advanced Pancreatic Cancer
However, the researchers noted that further studies assessing the use of SBRT for patients with LAPC are needed to improve…
High-Dose Focused Radiation after Surgical Removal of Pancreatic Tumors
A clinical trial looks at the effectiveness of stereotactic body radiation therapy in killing cancer cells in the margins after pancreatic tumor removal.
Testing the Effectiveness of Radiation and Standard Treatment
A clinical trial compares FOLFIRINOX plus stereotactic body radiation therapy (SBRT) with just FOLFIRINOX for pancreatic cancer that has spread locally.
More Effective Focused Radiation Therapy and Chemotherapy for Locally Advanced Pancreatic Cancer
A clinical trial tests whether adding Zometa makes chemotherapy and stereotactic body radiation therapy (SBRT) more effective against pancreatic cancer.
Finding the Best Dose of Radiation and an Experimental Drug
A clinical trial looks for the best dose of an experimental drug to combat the mouth sores that are a side effect of radiation treatment.
Failure is Not an Option
Christine Shaffer underwent chemotherapy and stereotactic body radiation therapy to shrink her tumor for surgery. She says failure is not an option.